# Convalescent Plasma Treatment in COVID-19

> **NCT04476888** · NA · COMPLETED · sponsor: **Aga Khan University** · enrollment: 110 (actual)

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** Convalescent Plasma (CP)
- **OTHER:** Drugs and supportive care

## Key facts

- **NCT ID:** NCT04476888
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-26
- **Primary completion:** 2020-09-15
- **Final completion:** 2020-10-10
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04476888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04476888, "Convalescent Plasma Treatment in COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04476888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*